Reuters
Reuters
@Reuters·4.2M subscribers·86.9K videos

LIVE: Dr. Fauci joins Reuters for an exclusive interview on the future of COVID-19

Posted

August 5, 2020

Views

30,303

Likes

317

Engagement

1.05%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

#Exclusive #coronavirus #COVID-19

Dr. Anthony Fauci joins Reuters for an exclusive interview on the future of COVID-19.

WASHINGTON (Reuters) - Drug manufacturers will likely have tens of millions of doses of a coronavirus vaccine in the early part of next year, with production ramping up so that it hits a billion doses by the end of 2021, Anthony Fauci, the top U.S. government official on infectious diseases, said in a Reuters interview on Wednesday.

Fauci said he has not seen any pressure from the White House to announce a vaccine close to the Nov. 3 election, in the hopes of boosting President Donald Trump’s re-election chances. He added that regulators have promised “they are not going to let political considerations interfere” with the approval of a COVID-19 vaccine and “safety and efficacy” will be primary considerations.

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on

Follow Reuters on Facebook

Follow Reuters on Twitter

Follow Reuters on Instagram

Guests & Subjects Covered

LIVECOVID- Dr Anthony FauciCOVID- WASHINGTON ReutersAnthony FauciWednesday FauciWhite HousePresident Donald TrumpsSubscribe Reuters

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.